Mori S - Search Results

1

Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.

Sakakura N, Mori S, Okuda K, Fukui T, Hatooka S, Shinoda M, Matsuo K, Yatabe Y, Yokoi K, Mitsudomi T. Sakakura N, et al. Among authors: mori s. Ann Thorac Surg. 2008 Oct;86(4):1084-90. doi: 10.1016/j.athoracsur.2008.04.117. Ann Thorac Surg. 2008. PMID: 18805136

2

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y. Mitsudomi T, et al. Among authors: mori s. J Clin Oncol. 2005 Apr 10;23(11):2513-20. doi: 10.1200/JCO.2005.00.992. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738541 Clinical Trial.

3

Primary lung adenocarcinoma with heterotopic bone formation.

Usami N, Yoshioka H, Mori S, Imaizumi M, Nagasaka T, Ueda Y. Usami N, et al. Among authors: mori s. Jpn J Thorac Cardiovasc Surg. 2005 Feb;53(2):102-5. doi: 10.1007/s11748-005-0010-1. Jpn J Thorac Cardiovasc Surg. 2005. PMID: 15782573

4

Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.

Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K, Sekido Y. Ito M, et al. Among authors: mori s. Cancer Lett. 2005 Jul 8;225(1):131-9. doi: 10.1016/j.canlet.2004.10.041. Epub 2004 Dec 22. Cancer Lett. 2005. PMID: 15922865

5

[Carney triad; report of a case].

Mori S, Yoshioka H, Fukui T, Usami N, Uchiyama M, Sato N, Ito M, Kaji M, Ueda Y. Mori S, et al. Kyobu Geka. 2005 Jul;58(7):597-601. Kyobu Geka. 2005. PMID: 16004346 Review. Japanese.

6

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.

Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T. Usami N, et al. Among authors: mori s. Cancer Sci. 2006 May;97(5):387-94. doi: 10.1111/j.1349-7006.2006.00184.x. Cancer Sci. 2006. PMID: 16630136 Free PMC article.

7

Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.

Shinoda M, Hatooka S, Mori S, Mitsudomi T. Shinoda M, et al. Among authors: mori s. Ann Thorac Cardiovasc Surg. 2006 Aug;12(4):234-41. Ann Thorac Cardiovasc Surg. 2006. PMID: 16977291 Review.

8

Significance of the number of positive lymph nodes in resected non-small cell lung cancer.

Fukui T, Mori S, Yokoi K, Mitsudomi T. Fukui T, et al. Among authors: mori s. J Thorac Oncol. 2006 Feb;1(2):120-5. J Thorac Oncol. 2006. PMID: 17409840 Free article.

9

Controversy about small peripheral lung adenocarcinomas: how should we manage them?

Fukui T, Sakakura N, Mori S, Hatooka S, Shinoda M, Yatabe Y, Mitsudomi T. Fukui T, et al. Among authors: mori s. J Thorac Oncol. 2007 Jun;2(6):546-52. doi: 10.1097/JTO.0b013e318060d30d. J Thorac Oncol. 2007. PMID: 17545852 Free article. Review.

10

A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204).

Kunitoh H, Kato H, Tsuboi M, Asamura H, Tada H, Nagai K, Mitsudomi T, Koike T, Nakagawa K, Ichinose Y, Okada M, Shibata T, Saijo N; JCOG Lung Cancer Surgical Study Group. Kunitoh H, et al. Br J Cancer. 2008 Sep 16;99(6):852-7. doi: 10.1038/sj.bjc.6604613. Br J Cancer. 2008. PMID: 18728643 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,361 results

Search Page

Filters